Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:EVOK
Date5/2013
Raised$23M
Post IPO Valuation

General Information

Websiteevokepharma.com
CategoryBioTech
Phone7604871255
Employees
Founded2007

Offices

San Diego, USA
12555 High Bluff Drive
Suite 385
San Diego, CA, 92130
USA

People

Board Member
Board Member

Funding

TOTAL $6M
FUNDING TOTAL $6M
Venture Round, 6/2010
$6M

Tags

Evoke Pharma

Evoke Pharma, Inc. is a privately held specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. The Company was established by experienced specialty pharmaceutical executives with a successful track record of acquiring, developing, registering, and marketing pharmaceutical products in the US.

Evoke has concentrated on the gastroenterology field due to the significant unmet medical needs, the opportunity to improve known products and its focused physician base. Despite the relatively high number of patients suffering from gastrointestinal diseases and disorders, there are only about 12,000 gastroenterologists in the U.S. These physicians conduct over 31 million patient visits and write almost 40 million prescriptions each year valued at $4.8 billion. Also, GI diseases may limit or alter the effectiveness of traditional oral therapies due to the disease for which the product is intended to treat. By developing enhanced versions of currently approved drug products, through novel delivery formats or formulations, Evoke intends to provide patients additional treatment options.

Evoke’s lead product candidate, EVK-001, is in late stage clinical testing. The company has exclusive rights to a novel formulation and delivery of a currently marketed GI product. The product is intended for the treatment of diabetic gastroparesis.

Evoke has advanced its product development activities by leveraging several corporate relationships with many external clinical, CMC, and regulatory experts. Evoke plans to continue this strategy of developing acquired products in partnership with various global organizations depending upon new acquisitions and appropriate asset investment.

Recent Milestones

  • Stock
    Went public with stock symbol NASDAQ:EVOK. (5/30/13)
    Posted 5/30/13 at 10:01pm
  • Dollar
    Evoke Pharma received $6M in Venture Round funding. (6/30/10)
    Posted 1/9/14 at 4:09am via sec.gov

Videos

Screenshots

Evoke Pharma screenshot
Above: Homepage
Uploaded: 1/9/14

Stock Price

Sources

  1. SEC (sec.gov) [edit]
Edit This Page
Last Edited 1/9/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy